Prof. Dr. Alexander Rosenkranz: Konservative- versus Nierenersatz-Therapie im Alter
Prof. Dr. Gert Mayer: Der labile Kalziumpool bei Patienten mit chronischer Nierenerkrankung
Prof. Dr. Thomas Benzing: Diagnose und Pathogenese von Zystennieren
Prof. DDr. Walter H. Hörl, FRCP: Was leistet die Nephrologie am AKH Wien
Prof. Dr. Rainer Oberbauer: Systembiologie in der Nephrologie
Prof. Dr. Marcus Säemann: Urämisches HDL: Von der immunologischen Dysfunktion zu neuen Biomarkern
Prof. Carlo Gaillard: Anaemia in ND-CKD: what really matters?
Angel de Francisco: Managing anaemia and improving patients' lives - where are we going?
Iain C Macdougall BSc, MD, FRCP: The safety of i.v. irons: current status
Piotr Ponikowski, MD, PhD, FESC: Benefits of intravenous iron in chronic heart failure patients
Dr. Iain Macdougall: Scientific perspectives on iron deficiency and its correction with intravenous iron
Dr. Josep Comin Colet, MD: Iron management in chronic heart failure patients: A guide for practitioners
Prof. Dr. med. Marco Maggiorini: Safe Computerized Glucose Control
Prof. Christoph Wanner: Iron and anaemia treatment: where are we going?
Prof. Bernard Canaud: Anaemia management in non-dialyses CKD
Dr. Iain Macdougall: Iron metabolism: where is the science taking us?
Dr. Simon Roger: Optimizing anaemia management: which is the right path?
Dr. Peter van der Meer: Iron-deficiency anaemia
Stefan D Anker, MD PhD: Intravenous iron for symptomatic patients with heart failure
Prof. Tiny Jaarsma: Living with chronic heart failure
Stefan D Anker, MD PhD: Iron therapie in chronic heart failure: first experience and outlook
Helmut Drexler MD: Anaemia and iron deficiency in heart failure: the Problem
Piotr Ponikowski, MD, PhD, FESC: Iron metabolism in heart failure: pathophysiology and diagnosis
Startseite | Sitemap | Standorte | Kontakt | Impressum